Latest Alexander's Inc (ALX) Headlines Alexander's

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Latest Alexander's Inc (ALX) Headlines

Alexander's Completes $300 Million Refinancing of 731 Lexington Avenue Office Space
Business Wire - Mon Mar 03, 8:08AM CST
ALEXANDER'S, INC. (NYSE: ALX) announced today that it has completed a $300 million refinancing of the office portion of 731 Lexington Avenue. The interest-only loan is at LIBOR plus 0.95%, currently 1.10%, and matures in March 2017, with four one-year extension options. The proceeds of the new loan were used to repay the existing $312 million 5.33% fixed-rate loan and closing costs.

Alexander's Announces Fourth Quarter FFO of $4.50 per share
Business Wire - Mon Feb 24, 8:05AM CST
ALEXANDER'S, INC. (NYSE: ALX) today reported:

The Graham Number: 5 Undervalued Stocks With Huge ROE
at The Street - Thu Feb 20, 4:04PM CST
James Dennin, Kapitall: The Graham Number is a great tool to find undervalued stocks by comparing earnings to book value. One [...]

Company Profile for RUSNANO USA
Business Wire - Fri Feb 07, 9:20AM CST
RUSNANO is a $10 billion state-backed investment fund headquartered in Moscow, Russia. With a primary focus on late-stage venture capital and private equity deals in nanotechnology, the company invests in life sciences, microelectronics, cleantech, energy efficiency, and advanced materials. Founded in 2007, RUSNANO has invested in more than 100 high-tech companies from Russia, the U.S., U.K., Israel, France, Germany, China, and other countries across the world. RUSNANO's interests in the U.S. and Canada are represented by RUSNANO USA, which oversees the firm's cooperation with American and Canadian companies, and the VC community. RUSNANO USA is involved in the management of RUSNANO's US portfolio companies, and also facilitates the marketing of Russian nanotechnology products in the global market.

Twitter Shows Why Big City Dividend Stocks Are Great
Reuben Brewer, The Motley Fool - Motley Fool - Mon Feb 03, 6:00AM CST
Twitter recently inked a deal to lease space in New York City. Although in the grand scheme of things the transaction isn't that big, it proves the value of a New York City address. That's why real estate investment trusts (REITs) with a focus on...

Alexander's Announces Vornado Realty Trust Quarterly Conference Call
Business Wire - Fri Jan 31, 1:33PM CST
ALEXANDER'S, INC. (NYSE:ALX) today announced that Vornado Realty Trust (NYSE:VNO), the manager which conducts Alexander's operations, will host a quarterly earnings conference call and an audio webcast on February 25, 2014 at 10:00 a.m. Eastern Time (ET). On the call, information concerning Alexander's may be discussed.

NYSE stocks posting largest volume increases
AP - Thu Jan 23, 5:03PM CST
NEW YORK (AP) — A look at the 10 biggest volume gainers on New York Stock Exchange at the close of trading:

Alexander's Declares an Increased Quarterly Dividend of $3.25 per Share (a New Indicated Annual Rate of $13.00)
Business Wire - Wed Jan 15, 9:28AM CST
Alexander's, Inc. (NYSE:ALX) today announced that its Board of Directors has declared an increased quarterly dividend of $3.25 per share (a new indicated annual rate of $13.00). The former annual rate was $11.00 per share. The dividend will be payable on February 18, 2014 to stockholders of record on January 27, 2014.

Alexander's Announces Third Quarter 2013 FFO of $4.12 per share
Business Wire - Mon Nov 04, 8:11AM CST
Alexander's, Inc. (NYSE:ALX) today reported:

Alexander's announces dividend of USD2.75 per share for quarter
M2 - Wed Oct 30, 7:23AM CDT
Real estate investment trust Alexander's Inc (NYSE:ALX) revealed on Tuesday that its board of directors approved a regular quarterly dividend of USD2.75 per share.

Alexander's Declares Quarterly $2.75 Dividend on Common Shares
Business Wire - Tue Oct 29, 3:53PM CDT
Alexander's, Inc. (NYSE:ALX) today announced that its Board of Directors has declared a regular quarterly dividend of $2.75 per share payable November 22, 2013 to stockholders of record on November 8, 2013.

Alexander's Down 15.5% Since SmarTrend Downtrend Call (ALX)
Comtex SmarTrend(R) - Thu Oct 10, 9:55AM CDT
SmarTrend identified a Downtrend for Alexander's (NYSE:ALX) on December 21st, 2012 at $337.60. In approximately 10 months, Alexander's has returned 15.52% as of today's recent price of $285.19.

Alexander's Shares Down -477.6% Since SmarTrend's Sell Call (ALX)
Comtex SmarTrend(R) - Wed Sep 18, 10:06AM CDT
SmarTrend identified a Downtrend for Alexander's (NYSE:ALX) on December 21st, 2012 at $337.60. In approximately 9 months, Alexander's has returned 477.62% as of today's recent price of $1,950.00.

17.2% Return Seen to Date on SmarTrend Alexander's Call (ALX)
Comtex SmarTrend(R) - Wed Sep 11, 9:30AM CDT
SmarTrend identified a Downtrend for Alexander's (NYSE:ALX) on December 21st, 2012 at $337.60. In approximately 9 months, Alexander's has returned 17.21% as of today's recent price of $279.50.

Alexander's Shares Down 19.1% Since SmarTrend's Sell Call (ALX)
Comtex SmarTrend(R) - Tue Sep 03, 5:23PM CDT
SmarTrend identified a Downtrend for Alexander's (NYSE:ALX) on December 21st, 2012 at $337.60. In approximately 9 months, Alexander's has returned 19.13% as of today's recent price of $273.00.

Alexander's Announces Second Quarter 2013 FFO of $3.98 per share
Business Wire - Mon Aug 05, 8:22AM CDT
ALEXANDER'S, INC. (New York Stock Exchange: ALX) today reported:

PWE, ALX, BABY, IMO, HCBK, THFF Expected To Be Up Before Next Earnings Releases
M2 - Fri Jul 19, 5:07AM CDT
BUYINS.NET / www.squeezetrigger.com is monitoring the performance of all stocks with earnings being released in the coming weeks and determining how the stocks have performed Before their last 12 quarterly, 6 quarterly and June earnings reports. Powertech Uranium Corp (NYSE WE), Alexander's Inc (NYSE:ALX), NATUS MEDICAL, INCORPORATION (NASDAQ:BABY), Imperial Oil Ltd (AMEX:IMO), Hudson City Bancorp Inc (NASDAQ:HCBK), FIRST FINANCIAL CORPORATION (NASDAQ:THFF) are all expected to be Up Before their earnings are released. The movement of stock prices in the days and weeks leading to and following these earnings announcements may follow a predictable pattern. Most companies stock price histories show random or unpredictable movements around earnings dates. But some seem to repeat the same pattern quarter after quarter, year after year. The # of Reports in the table below shows how many previous quarterly reports comprise the indicator that predicts how a stock will act after its earnings are released. The specific technology used to make these predictions is available for a low monthly fee at http://www.squeezetrigger.com/services/strat/mh.php . The following stocks are expected to go Up Before earnings are released Thursday:

Alexander's (ALX) Stock Research Links

ALX Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Sean Trahan Joins Citrin Cooperman: New Tax Lead

Updated Category News Views 7

Citrin Cooperman's Strategic Tax Move If there's one phrase that can spark a debate at a financial water cooler, it's 'transfer pricing.' Today, Citrin Cooperman is throwing its hat further into that ring with the appointment of Sean Trahan as head of their new Transfer Pricing and Value Chain Optimization Practice. This isn't just another reshuffling of office...

Continue Reading
Davos Healthcare Aims to Revolutionize Hospital Ratings

Updated Category News Views 6

Throw away those dusty, old reputation surveys—Davos Healthcare just turned the spotlight onto cold, hard data with its new global hospital evaluation platform. Why Davos Healthcare’s Initiative Matters At the C3 US NYC Davos of Healthcare™ Summit, an event that’s rooted itself alongside the United Nations General Assembly, Davos Healthcare unveiled a...

Continue Reading
AI-Driven Lumi Transforms Car Dealership Interactions

Updated Category News Views 7

Lumi: Changing the Car Buying Game Picture this: You're browsing for a new car, head filled with specifics like towing capacity, price points, and trim options. Usually, such queries would send you bouncing around the web, but Lectrium's Lumi promises to keep the questioning—and decision-making—right on the dealership's page. In a move set to shake up the game,...

Continue Reading
Dr. Desi Bartlett Teams Up with Glo for Perimenopause Focus

Updated Category News Views 4

Glo Taps Top Wellness Expert for Women's Health Initiative In an industry brimming with wellness voices, it's rare to find one that marries scholarly acumen with authentic, personal teaching. Yet, this is precisely what Dr. Desi Bartlett brings to the table as she partners with Glo to offer new fitness programming specifically targeting women facing perimenopause and...

Continue Reading
FJBio Boosts Antibody Discovery with Sapio AI

Updated Category News Views 5

In the sprawling world of antibody discovery, where every scrap of data can make or break the next big breakthrough, FairJourney Bio (FJBio) is pulling out all the stops. They've teamed up with Sapio Sciences to ditch the paperwork nightmares and usher in a new era of AI-driven efficiency. With operations stretching from Porto to Cambridge to sunny San Diego, they’re...

Continue Reading
Cracking the Code of America's Delivery Addiction

Updated Category News Views 4

America's New Obsession: Convenience at a Cost Diving into the relentless hustle, Americans are shelling out big bucks to dodge life's mundane chores. A fresh survey dished out by FinanceBuzz, hitching a ride with Bank of America, gives us a peek into how hooked everyone is on convenience services like food and grocery deliveries. It’s clear people are ready to fork...

Continue Reading
Succession Planning in Turmoil: Only 42% Ready

Updated Category News Views 5

Diving into the Succession Crisis in Finance Succession planning in the financial advisory space is like retirement planning for the rest of us—everyone knows it's crucial, yet too many put it off. Despite the looming retirement wave and desperate interest from the younger cohort, a staggering 42% of financial advisors are still without a documented succession game...

Continue Reading
The Chemical Industry and EPA: A Broken System?

Updated Category News Views 6

Decades of an Unchecked Revolving Door The Environmental Protection Agency (EPA) and chemical manufacturers—a dance that’s been going on for what seems like forever. But not in the way you might hope. We're talking about a revolving door where execs and lobbyists waltz into regulatory chairs while regulators slide into cushy industry gigs. Wisner Baum LLP, a stickler...

Continue Reading
Leapora's Taskeen: Redefining Task Accountability

Updated Category News Views 5

AI's Impact on Workplace Task Management In today’s whirlwind of AI-generated output, transparency is not just a luxury; it’s a necessity. AI systems churn out work that can appear polished but often lacks substance. This doesn't just create headaches; it triggers a ticking bomb in the regulatory department. According to a 2025 survey from Stanford and BetterUp Labs,...

Continue Reading
FutureVault's AI Agents: Transforming Financial Workflows

Updated Category News Views 4

Revolutionizing Financial Operations: FutureVault's AI Approach In the dizzying whirlwind of financial services, the launch of FutureVault AI Agents is a game-changer for document management. This isn't some half-baked tool; it's a full-fledged overhaul of how compliance and operations should tick in the modern age. We've all seen it—a paper trail tangled across systems...

Continue Reading

Top 5 Most Recently Viewed Articles

PMGC Capital's Strategic Investment in Alaunos Therapeutics

Updated Category News Views 171

PMGC Capital LLC Plans to File Schedule 13D on Alaunos PMGC Capital LLC, a fully owned subsidiary of PMGC Holdings Inc. (Nasdaq: ELAB), has made a significant move in the financial landscape by announcing its intention to file a Schedule 13D with the U.S. Securities and Exchange Commission (SEC). This filing will disclose its beneficial ownership in Alaunos Therapeutics,...

Continue Reading
Black Diamond Therapeutics: Pivotal Developments Ahead

Updated Category News Views 97

Black Diamond Therapeutics Continues to Make Strides Recently, H.C. Wainwright confirmed a Buy rating on Black Diamond Therapeutics (NASDAQ: BDTX) shares, projecting a price target of $11.00. This positive outlook follows the company's major restructuring efforts aimed at advancing BDTX-1535, its leading drug candidate, into pivotal trials. This move is expected to not...

Continue Reading
Eureka Acquisition Corp Announces New Meeting Date and Deadlines

Updated Category News Views 187

Eureka Acquisition Corp's Important Announcement New York — Eureka Acquisition Corp (NASDAQ: EURK), a special purpose acquisition company, has recently made significant announcements regarding the schedule of its extraordinary general meeting. Originally set for June 20, it will now take place on June 25, providing shareholders with extra time for participation. Details...

Continue Reading
Diamedica Therapeutics Hits New Heights with $6.41 Stock Value

Updated Category News Views 118

Diamedica Therapeutics Inc. Achieves 52-Week High Diamedica Therapeutics Inc. (NASDAQ: DMAC) is making headlines as its stock has recently hit a remarkable 52-week high of $6.41. This impressive milestone comes amid a significant growth phase for the company, which is currently valued at around $230 million. The steep rise in the stock price over the past year indicates a...

Continue Reading
J.P. Morgan's Projections for 2025: Capital Market Insights

Updated Category News Views 6083

J.P. Morgan's Capital Market Assumptions for 2025 J.P. Morgan Asset Management has recently unveiled its 2025 Long-Term Capital Market Assumptions (LTCMAs), providing valuable insights into the anticipated returns and risks across various asset classes for the next decade. These projections serve as a compass for investment strategies, targeting institutional and...

Continue Reading